Patent · US Expired

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones

US7202260B2 · kind B2 · utility

4Cited by

1References

14Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Andreas Huth · Berlin, DE
Martin Krueger · Berlin, DE
Ludwig Zorn · Berlin, DE
Stuart Ince · Berlin, DE
Rolf Bohlmann · Berlin, DE
Karl-Heinz Thierauch · Berlin, DE
Andreas Menrad · Berlin, DE
Martin Haberey · Berlin, DE
Holger Hess-Stumpp · Berlin, DE

Key dates

Filing date	Jun 14, 2004
Grant date	Apr 10, 2007
Priority date	—
Expiry date	Sep 18, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D213/64
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Novel VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones and their use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are selected.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.